Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2026-05-09 @ 5:00 AM
Study NCT ID:
NCT01167166
Status:
COMPLETED
Last Update Posted:
2017-06-26
First Post:
2010-07-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of 72-hour and 120-hour Infusion of Rigosertib in Acute Myeloid Leukemia (AML) and Acute Lymphoid Leukemia (ALL)
Sponsor:
Traws Pharma, Inc.
Organization:
Conditions & Keywords Data
Conditions: